A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
Bone Mass Response to Discontinuation of Long-term Hormone Replacement TherapyResults From the Postmenopausal Estrogen/Progestin Interventions (PEPI) Safety Follow-up Study
2002
Archives of Internal Medicine
for the PEPI Safety Follow-up Study (PSFS) Investigators Background: Accelerated bone loss after stopping hormone therapy (HRT) is postulated to explain the lack of hip-fracture protection conferred by former HRT use. The abbreviation HRT (traditionally standing for "hormone replacement therapy") is used herein because of its wide recognition in the field. However, the pharmacological doses of estrogens and progestins used are not truly "replacement" in nature. Objectives: To determine whether
doi:10.1001/archinte.162.6.665
pmid:11911720
fatcat:eck3ulpjlnf73jz4znazsip3uy